Newron Pharmaceuticals S.p.A. NWRN.SW
NWRN.SW
Newron Pharmaceuticals S.p.A. CLTN.SW
COLTENE Holding AG DOCM.SW
DocMorris AG VBSN.SW
IVF Hartmann Holding AG SANN.SW
Santhera Pharmaceuticals Holding AG MOLN.SW
Molecular Partners AG RLF.SW
Relief Therapeutics Holding AG ADXN.SW
Addex Therapeutics Ltd BSLN.SW
Basilea Pharmaceutica AG EVE.SW
EvoNext Holdings S.A.
Newron Pharmaceuticals S.p.A. CLTN.SW
COLTENE Holding AG DOCM.SW
DocMorris AG VBSN.SW
IVF Hartmann Holding AG SANN.SW
Santhera Pharmaceuticals Holding AG MOLN.SW
Molecular Partners AG RLF.SW
Relief Therapeutics Holding AG ADXN.SW
Addex Therapeutics Ltd BSLN.SW
Basilea Pharmaceutica AG EVE.SW
EvoNext Holdings S.A.
Performance
| Periode | NWRN.SW | CLTN.SW | DOCM.SW | VBSN.SW | SANN.SW | MOLN.SW | RLF.SW | ADXN.SW | BSLN.SW | EVE.SW |
|---|---|---|---|---|---|---|---|---|---|---|
| 6M | 98.52 % | -25.66 % | -36.18 % | -12.89 % | -25.82 % | -13.83 % | 10.50 % | 20.72 % | 17.73 % | -32.62 % |
| YTD | 52.33 % | -11.02 % | -68.67 % | -7.67 % | -28.08 % | -36.00 % | -40.23 % | -8.18 % | 16.02 % | -24.59 % |
| 1Y | 49.78 % | -12.40 % | -79.50 % | -1.77 % | 13.41 % | -50.26 % | -56.89 % | -23.48 % | 7.00 % | 1.48 % |
| 3Y | 952.55 % | -40.92 % | -75.34 % | 25.91 % | 68.01 % | -55.00 % | -76.09 % | -56.71 % | 12.90 % | -96.17 % |
| 5Y | 637.36 % | -34.87 % | -97.23 % | -20.40 % | -68.39 % | -82.65 % | -98.71 % | -96.81 % | -3.39 % | -98.48 % |
| 10Y | -54.51 % | -21.61 % | -95.88 % | -10.65 % | -98.98 % | -91.70 % | -86.85 % | -98.07 % | -53.84 % | -99.66 % |
| From the beginning | -76.86 % | -51.40 % | -95.88 % | 1 479.25 % | -98.85 % | -87.51 % | -99.98 % | -99.91 % | -52.00 % | -99.97 % |